Savannah, GA – An affiliation agreement was signed on October 1st between St. Joseph’s/Candler and the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.
The agreement provides residents of Coastal Georgia and South Carolina, the availability of Clinical Research Trials from a National Cancer Institute (NCI) designated Comprehensive Cancer Center without leaving the local community.
NCI designated Comprehensive Cancer Centers demonstrate extensive research activities in three major categories: basic, clinical and prevention, control and population based research, and exhibits a strong body of interactive research that bridges these scientific areas. These centers provide the translation of research into clinical and educational programs for oncology professionals and patients.
St. Joseph’s/Candler has a historical reputation for providing high quality cancer care within the community and has the benefit of an established infrastructure to support extensive clinical trials and research programs. Therefore, the establishment of an affiliation with an NCI designated facility was a natural fit and one, which represents the largest benefit for cancer patients in the region.
Through the agreement, physicians and patients of St. Joseph’s/Candler’s Institute for Regional Cancer Care will now have access to an enhanced, academic affiliated institute with advanced scientific, clinical, research and treatment activities.
The affiliation agreement was motivated by physicians and leadership at the Institute for Regional Cancer Care who seek to make available to patients advanced clinical research, and multi-disciplinary approaches to treatment, to continually improve patient care and offer the best options for patients.
The H. Lee Moffitt Cancer Center and Research Institute, a not-for-profit facility, is located in Tampa, Florida. Since its opening in 1986, the Moffitt Cancer Center has received designation as a Comprehensive Cancer Center by the National Cancer Institute. This coveted designation is the highest level of recognition that can be given to a cancer center. The Center has more than 280 physicians and 600 researchers.